<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Virulence</journal-id><journal-id journal-id-type="iso-abbrev">Virulence</journal-id><journal-title-group><journal-title>Virulence</journal-title></journal-title-group><issn pub-type="ppub">2150-5594</issn><issn pub-type="epub">2150-5608</issn><publisher><publisher-name>Taylor &#x00026; Francis</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38018865</article-id><article-id pub-id-type="pmc">PMC10732598</article-id>
<article-id pub-id-type="doi">10.1080/21505594.2023.2287339</article-id><article-id pub-id-type="publisher-id">2287339</article-id><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of Record</article-version><article-categories><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Paper</subject></subj-group></article-categories><title-group><article-title>LRRC8A promotes <italic toggle="yes">Glaesserella parasuis</italic> cytolethal distending toxin-induced p53-dependent apoptosis in NPTr cells</article-title><alt-title alt-title-type="left-running-head">W. MAO ET AL.</alt-title><alt-title alt-title-type="right-running-head">VIRULENCE</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mao</surname><given-names>Weiting</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="an0002" ref-type="author-notes">
<sup>#</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Zhichao</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="an0002" ref-type="author-notes">
<sup>#</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wen</surname><given-names>Siting</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lin</surname><given-names>Yan</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gu</surname><given-names>Jiayun</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Ju</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Huan</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Cao</surname><given-names>Qi</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Yindi</given-names></name><xref rid="aff0003" ref-type="aff">
<sup>c</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Xiaojuan</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Cai</surname><given-names>Xuwang</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref><xref rid="an0001" ref-type="corresp"/><xref rid="an0002" ref-type="author-notes">
<sup>#</sup>
</xref></contrib><aff id="aff0001"><label>a</label>National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, <institution-wrap><institution>Huazhong Agricultural University</institution></institution-wrap>, <city>Wuhan</city>, <country>China</country></aff><aff id="aff0002"><label>b</label>Key Laboratory of Preventive Veterinary Medicine in Hubei Province, <institution-wrap><institution>Cooperative Innovation Center for Sustainable Pig Production</institution></institution-wrap>, <city>Wuhan</city>, <country>China</country></aff><aff id="aff0003"><label>c</label>Institute of Animal Husbandry and Veterinary Research, <institution-wrap><institution>Henan Academy of Agricultural Sciences</institution></institution-wrap>, <city>Zhengzhou</city>, <country>China</country></aff></contrib-group><author-notes><corresp id="an0001">CONTACT Xuwang Cai <email xlink:href="mailto:caixuwang@mail.hzau.edu.cn">caixuwang@mail.hzau.edu.cn</email></corresp><fn id="an0002"><label>#</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date date-type="pub" publication-format="electronic"><day>29</day><month>11</month><year>2023</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2023</year></pub-date><pub-date pub-type="pmc-release"><day>29</day><month>11</month><year>2023</year></pub-date><volume>14</volume><issue>1</issue><elocation-id seq="107">2287339</elocation-id><pub-history><event event-type="tagger"><event-desc>Integra</event-desc><date><day>29</day><month>11</month><year>2023</year></date></event><event event-type="final"><event-desc>Integra</event-desc><date><day>29</day><month>11</month><year>2023</year></date></event><event event-type="received"><date><day>14</day><month>10</month><year>2023</year></date></event><event event-type="revised"><date><day>11</day><month>11</month><year>2023</year></date></event><event event-type="accepted"><date><day>19</day><month>11</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#x000a9; 2023 The Author(s). Published by Informa UK Limited, trading as Taylor &#x00026; Francis Group.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="KVIR_14_2287339.pdf"/><abstract><title>ABSTRACT</title><p><italic toggle="yes">Glaesserella parasuis</italic> is an early colonizer of the swine upper respiratory tract and can break through the respiratory barrier for further invasion. However, the mechanisms underlying <italic toggle="yes">G. parasuis</italic> increases epithelial barrier permeability remain unclear. This study demonstrates that <italic toggle="yes">G. parasuis</italic> cytolethal distending toxin (CDT) induces p53-dependent apoptosis in new-born piglet tracheal (NPTr) cells. Moreover, we report for the first time that leucine-rich repeat-containing protein 8A (LRRC8A), an essential subunit of the volume-regulated anion channel (VRAC), involves in apoptosis of NPTr cells mediated by <italic toggle="yes">G. parasuis</italic> CDT. Pharmacological inhibition of VRAC with either PPQ-102 or NS3728 largely attenuated CDT-induced apoptosis in NPTr cells. Additionally, experiments with cells knocked down for LRRC8A using small interfering ribonucleic acid (siRNA) or knocked out LRRC8A using CRISPR/Cas9 technology showed a significant reduction in CDT-induced apoptosis. Conversely, re-expression of <italic toggle="yes">Sus scrofa</italic> LRRC8A in <italic toggle="yes">LRRC8A</italic><sup>&#x02013;<italic toggle="yes">/</italic>&#x02013;</sup> NPTr cells efficiently complemented the CDT-induced apoptosis. In summary, these findings suggest that LRRC8A is pivotal for <italic toggle="yes">G. parasuis</italic> CDT-induced apoptosis, providing novel insights into the mechanism of apoptosis caused by CDT.</p></abstract><kwd-group kwd-group-type="author"><title>KEYWORDS</title><kwd>Glaesserella parasuis</kwd><kwd>cytolethal distending toxin</kwd><kwd>cell apoptosis</kwd><kwd>p53 signalling</kwd><kwd>LRRC8A</kwd></kwd-group><support-group><funding-group><award-group><funding-source>
<institution-wrap><institution>National Key Research and Development Program Special Project</institution></institution-wrap>
</funding-source><award-id>2022YFD1800902</award-id></award-group><award-group><funding-source>
<institution-wrap><institution>China Agriculture Research System of the MOF and MARA</institution></institution-wrap>
</funding-source></award-group><funding-statement>This work was supported by the National Key Research and Development Program Special Project (No. 2022YFD1800902) and the China Agriculture Research System of the MOF and MARA (No. CARS-35).</funding-statement></funding-group></support-group><counts><fig-count count="8"/><table-count count="2"/><ref-count count="47"/><page-count count="1"/></counts></article-meta></front><body><sec sec-type="intro" disp-level="1" id="s0001"><title>Introduction</title><p><italic toggle="yes">Glaesserella parasuis</italic> (formerly known as <italic toggle="yes">Haemophilus parasuis</italic>) is a commensal organism of the upper respiratory tract of swine and is the aetiological agent of Gl&#x000e4;sser&#x02019;s disease, characterized by fibrous polyserositis, meningitis, and arthritis [<xref rid="cit0001" ref-type="bibr">1</xref>]. However, the molecular mechanisms underlying <italic toggle="yes">G. parasuis</italic> interactions with host cells are largely unknown, which makes it challenging to prevent and control the disease.</p><p>Cytolethal distending toxin (CDT) is a significant element in Gl&#x000e4;sser&#x02019;s disease. CDT is a bacterial exotoxin secreted by several Gram-negative pathogenic bacteria such as <italic toggle="yes">Actinobacillus actinomycetemcomitans</italic> [<xref rid="cit0002" ref-type="bibr">2</xref>], <italic toggle="yes">Escherichia coli</italic> [<xref rid="cit0003" ref-type="bibr">3</xref>], <italic toggle="yes">Haemophilus ducreyi</italic> [<xref rid="cit0004" ref-type="bibr">4</xref>,<xref rid="cit0005" ref-type="bibr">5</xref>], <italic toggle="yes">Campylobacter</italic> spp. (<italic toggle="yes">C. jejuni</italic>, <italic toggle="yes">C. fetus</italic>, <italic toggle="yes">C. coli</italic>, <italic toggle="yes">C. upsaliensis</italic>, <italic toggle="yes">C. hyointestinalis</italic>, and <italic toggle="yes">C. lari</italic>) [<xref rid="cit0006" ref-type="bibr">6</xref>], and <italic toggle="yes">Providencia alcalifaciens</italic> [<xref rid="cit0007" ref-type="bibr">7</xref>]. Generally, the pathogenicity of CDT is reflected in two aspects. On the one hand, CDT is capable of inducing apoptosis in B and T lymphocytes to downregulate the host immune response, allowing bacterial proliferation and causing more tissue damage [<xref rid="cit0008" ref-type="bibr">8</xref>]. In contrast, the ability of CDT to induce cell death results in increased epithelial barrier permeability, which enables bacterial invasion [<xref rid="cit0009" ref-type="bibr">9</xref>]. A complete CDT consists of three subunits: CdtA, CdtB, and CdtC [<xref rid="cit0010" ref-type="bibr">10</xref>]. CdtA and CdtC mainly bind to lipid rafts, which is a mechanism responsible for the translocation of the catalytic subunit CdtB into cells. CdtB entering the cell acts as a nuclease similar to DNase I and ultimately leads to irreversible cell cycle arrest and cell apoptosis through DNA damage [<xref rid="cit0011" ref-type="bibr">11&#x02013;13</xref>]. However, the effect of <italic toggle="yes">G. parasuis</italic> CDT on the respiratory tract has not been studied.</p><p>The p53 signalling pathway is essential for the regulation of cell cycle progression, DNA damage response, and apoptosis [<xref rid="cit0014" ref-type="bibr">14</xref>]. In some abnormal cellular conditions, such as DNA damage, p53 protein binds to the corresponding site of the gene and exerts its effect as a special transcription factor to induce cell cycle arrest, which would allow sufficient time to repair DNA or induce apoptosis if repaired unsuccessfully [<xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0015" ref-type="bibr">15</xref>]. Two distinct pathways, the death receptor pathway and the mitochondrial pathway, can lead to apoptosis [<xref rid="cit0016" ref-type="bibr">16</xref>]. In the mitochondrial pathway, the anti-apoptotic protein B cell lymphoma 2 (Bcl-2), located in the outer mitochondrial membrane <italic toggle="yes">via</italic> heterodimerization with the pro-apoptotic protein Bcl-2-associated X (BAX), controls apoptosis [<xref rid="cit0017" ref-type="bibr">17</xref>]. Notably, p53-dependent apoptosis involves the mitochondrial pathway, including the neutralization of Bcl-2, release of BAX, mitochondrial outer membrane permeabilization (MOMP), and activation of caspase-9 and caspase-3 [<xref rid="cit0018" ref-type="bibr">18</xref>].</p><p>A pivotal standpoint is that apoptosis is generally accompanied by volume changes that represent the flow of intracellular ions [<xref rid="cit0019" ref-type="bibr">19</xref>]. Extensive research has shown that apoptosis volume decrease (AVD), involving the volume-regulated anion channel (VRAC), is a prerequisite for apoptotic events and results in cell contraction at the onset of apoptosis [<xref rid="cit0020" ref-type="bibr">20</xref>,<xref rid="cit0021" ref-type="bibr">21</xref>]. VRAC is ubiquitously expressed in almost all types of vertebrate cells and is the key player in regulating cell volume by mediating the efflux of Cl<sup>&#x02013;</sup> and some organic osmolytes such as taurine [<xref rid="cit0022" ref-type="bibr">22</xref>]. It is now believed that leucine-rich repeat-containing protein 8A (LRRC8A), also named SWELL1, is the only mandatory subunit of VRAC, but it has to combine with at least another LRRC8 protein (LRRC8B &#x02013; E) to produce a functional channel complex [<xref rid="cit0023" ref-type="bibr">23&#x02013;25</xref>]. In addition to cell volume regulation and participation in apoptosis, LRRC8A has also been associated with cell proliferation, oxidative stress, insulin secretion by &#x003b2; cells, and anti-viral immunity [<xref rid="cit0026" ref-type="bibr">26&#x02013;29</xref>]. With respect to the role of LRRC8A in apoptosis, previous studies have focused on the resistance of cells to anticancer drugs such as cisplatin and temozolomide, which induce apoptosis <italic toggle="yes">via</italic> DNA damage [<xref rid="cit0030" ref-type="bibr">30&#x02013;33</xref>]. However, it remains unclear whether LRRC8A functions in the process of apoptosis induced by bacterial CDT, which causes DNA damage similar to cisplatin and temozolomide.</p><p>In the present study, we investigated the effect of <italic toggle="yes">G. parasuis</italic> CDT on new-born piglet tracheal (NPTr) cells and the potential role of LRRC8A in this process. Our study supports the notion that LRRC8A plays a central role in <italic toggle="yes">G. parasuis</italic> CDT-induced apoptosis and provides new insights into its function as an effector or biomarker of apoptosis.</p></sec><sec disp-level="1" id="s0002"><title>Materials and methods</title><sec disp-level="2" id="s0002-s2001"><title>Plasmids, antibodies and reagents</title><p>For recombinant expression in <italic toggle="yes">E. coli</italic> BL21 (DE3), <italic toggle="yes">cdtA, cdtB</italic>, and <italic toggle="yes">cdtC</italic> of <italic toggle="yes">G. parasuis</italic> were inserted into the pET-30a plasmid encoding an N-terminal His<sub>6</sub>-tag. For stable expression of LRRC8A, the sequence of <italic toggle="yes">LRRC8A</italic> was inserted into the pcDNA3.1 vector and transformed into <italic toggle="yes">LRRC8A</italic><sup>&#x02013;<italic toggle="yes">/</italic>&#x02013;</sup> NPTr cells. All the plasmids used in this study were verified by DNA sequencing. The bacterial strains and plasmids used are listed in <xref rid="t0001" ref-type="table">Table 1</xref>.<table-wrap position="float" id="t0001"><label>Table 1.</label><caption><p>Bacterial strains and plasmids used in this study.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*" align="left"/><col width="1*" align="left"/><col width="1*" align="left"/></colgroup><thead><tr><th align="left">Strain or plasmid</th><th align="center">Genotype and/or phenotype</th><th align="center">Reference or source</th></tr></thead><tbody><tr><td align="left"><italic toggle="yes">E. coli</italic> DH5&#x003b1;</td><td align="left">A cloning vector: F<sup>&#x02212;</sup>, &#x003c6;80<italic toggle="yes">lacZ</italic>&#x00394;M15&#x00394; (<italic toggle="yes">lacZY</italic>A-<italic toggle="yes">argF</italic>) U169, <italic toggle="yes">deoR</italic>, <italic toggle="yes">recA1</italic>, <italic toggle="yes">endA1</italic>, <italic toggle="yes">hsdR17</italic> (rk<sup>&#x02212;</sup>, mk<sup>+</sup>), <italic toggle="yes">phoA</italic>, <italic toggle="yes">supE44</italic>, &#x003bb;<sup>&#x02212;</sup>, <italic toggle="yes">thi-</italic>1, <italic toggle="yes">gyrA96</italic>, <italic toggle="yes">relA</italic>1</td><td align="left">TaKaRa Bio Inc., Dalian, China</td></tr><tr><td align="left"><italic toggle="yes">E. coli</italic> BL21 (DE3)</td><td align="left">F<sup>&#x02212;</sup>, <italic toggle="yes">ompT</italic>, <italic toggle="yes">hsdS</italic><sub><italic toggle="yes">B</italic></sub> (r<sub>B</sub><sup>&#x02212;</sup>m<sub>B</sub><sup>&#x02212;</sup>), <italic toggle="yes">gal</italic>, <italic toggle="yes">dcm</italic> (DE3)</td><td align="left">Invitrogen, Carlsbad, CA, USA</td></tr><tr><td align="left">pET30a</td><td align="left">Expression vector; Kan<sup>r</sup></td><td align="left">Novagen, Madison, WI, USA</td></tr><tr><td align="left">pET-30a<italic toggle="yes">cdtA/B/C</italic></td><td align="left">Genomic sequence available</td><td align="left">This laboratory</td></tr><tr><td align="left">YSY-spCas9-Puro</td><td align="left">CRISPR/Cas9 KO vector, Puro<sup>r</sup></td><td align="left">YSY biotech, Nanjing, China</td></tr><tr><td align="left">pcDNA3.1</td><td align="left">Expression vector; Amp<sup>r</sup></td><td align="left">Invitrogen, Carlsbad, CA, USA</td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p>Kan<sup>r</sup>, kanamycin-resistance; Amp<sup>r</sup>, ampicillin-resistance.</p></fn></table-wrap-foot></table-wrap></p><p>Antibodies against phosphorylated p53 (p-p53), p53, and His<sub>6</sub>-tag were obtained from ABclonal (Wuhan, Hubei, China), and antibodies against Bcl-2, BAX, and Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were purchased from Proteintech (Wuhan, Hubei, China). The antibody against LRRC8A was obtained from Abcam (Cambridge, UK).</p><p>The reagents were purchased as follows: Annexin V-fluorescein isothiocyanate (Annexin V-FITC)/propidium iodide (PI) Kit from 4A Biotech (Beijing, China); VRAC inhibitors PPQ-102 and NS3728 from MedChemExpress (Monmouth Junction, NJ, USA), and GreenNuc<sup>TM</sup> Caspase-3 Assay Kit for Live Cells from Beyotime (Shanghai, China). Unless otherwise noted, all other chemicals and reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA).</p></sec><sec disp-level="2" id="s0002-s2002"><title>Cell culture and treatment</title><p>A new-born piglet tracheal (NPTr) cell line was obtained based on continuous culture of primary cells derived from tracheal tissues [<xref rid="cit0034" ref-type="bibr">34</xref>]. NPTr cells were cultured in Dulbecco&#x02019;s Modified Eagle&#x02019;s Medium (DMEM)-high glucose supplemented with 10% foetal bovine serum (FBS) (Gibco, Grand Island, NY, USA). All cells were maintained at 37&#x000b0;C in an incubator containing 5% CO<sub>2</sub> and tested to be <italic toggle="yes">Mycoplasma</italic>-negative for mycoplasma using the standard PCR method [<xref rid="cit0035" ref-type="bibr">35</xref>].</p><p>Cells were pre-seeded overnight in 6-well plates (1&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells) until 60% confluence was reached the next day. Different doses of CDT were added to the culture medium. Relevant experiments were conducted after 36&#x02009;h. To inhibit the activity of VRAC, cells were pre-treated with either the VRAC inhibitor PPQ-102 or NS3728 for 2&#x02009;h before supplementation with CDT. The final doses were 500&#x02009;ng/mL for CDT, 30&#x02009;&#x003bc;M for PPQ-102, and 10&#x02009;&#x003bc;M for NS3728.</p></sec><sec disp-level="2" id="s0002-s2003"><title>Immunofluorescence staining</title><p>Cells grown on confocal dishes were treated with 100 MOI live bacteria or 500&#x02009;ng/mL CDT for 36&#x02009;h. Cells were fixed in 4% paraformaldehyde for 30&#x02009;min. The cells were incubated with 0.5% Triton X-100 in phosphate-buffered saline (PBS) for 15&#x02009;min. After blocking in 5% bovine serum for 1&#x02009;h at room temperature, the cells were incubated with rabbit anti &#x003b3;H2AX monoclonal antibody (Cell signalling technology, Denver, MA, USA) at 4&#x000b0;C overnight. The confocal dishes were washed and incubated with Cy3-conjugated secondary antibodies for 1&#x02009;h and DAPI for 15&#x02009;min. Anti-fade solution was added to the confocal dishes and the confocal dishes were visualized using a Zeiss LSM 510 META fluorescence microscope (Oberkochen, Baden-W&#x000fc;rttemberg, Germany).</p></sec><sec disp-level="2" id="s0002-s2004"><title>Cell viability and lactate dehydrogenase release assay</title><p>Cells were seeded in 96-well plates. Then stimulated with 100 MOI of live bacteria or 500&#x02009;ng/mL CDT for 36&#x02009;h. Cell viability was measured by cell counting kit-8 (CCK-8) assay (Yeasen, Shanghai, China), and lactate dehydrogenase (LDH) was measured using LDH cytotoxicity assay kit (Beyotime, Shanghai, China). These experiments were performed according to the manufacturer&#x02019;s protocol and repeated three times.</p></sec><sec disp-level="2" id="s0002-s2005"><title>Expression and purification of recombinant proteins</title><p>To obtain <italic toggle="yes">G. parasuis</italic> CdtA, CdtB, and CdtC recombinant proteins, <italic toggle="yes">E. coli</italic> BL21 (DE3) harbouring the expression vector was cultured at 37&#x000b0;C and induced by adding isopropyl-&#x003b2;-D-thiogalactopyranoside (IPTG) to a final concentration of 0.1&#x02009;mM when OD<sub>600&#x02009;nm</sub> reached 0.5&#x02013;0.6, followed by incubation at 37&#x000b0;C for 8&#x02009;h. A total of 400&#x02009;mL bacterial cultures were harvested and subsequently resuspended in 40&#x02009;mL buffer A (50&#x02009;mM Tris-base, 0.5&#x02009;mM EDTA, 50&#x02009;mM NaCl, pH 8.0), and disrupted by sonication at 400 W for 5&#x02009;min (Sonics, Newtown, CT, USA). Inclusion bodies were isolated by centrifugation at 6,000&#x02009;&#x000d7;&#x02009;<italic toggle="yes">g</italic> for 30&#x02009;min at 4&#x000b0;C and washed three times with 40&#x02009;mL of buffer A. The washed inclusion bodies were solubilized in 40&#x02009;mL buffer A supplemented with 5&#x02009;mM dithiothreitol (DTT) and 750&#x02009;mg/mL sodium lauroylsarcosinate (SKL) at 4&#x000b0;C for 12&#x02009;h. Then, the precipitates were isolated by centrifugation at 6,000&#x02009;&#x000d7;&#x02009;<italic toggle="yes">g</italic> for 30&#x02009;min at 4&#x000b0;C, followed by the addition of 800&#x02009;&#x003bc;L refolding buffer (20% PEG4000, 100&#x02009;mM reduced glutathione, 50&#x02009;mM oxidized glutathione) at 4&#x000b0;C for 2&#x02009;h. The samples were dialysed against 1&#x02009;&#x000d7;&#x02009;TE buffer (pH 8.0) at 4&#x000b0;C for 72&#x02009;h. N-terminal His<sub>6</sub>-tagged CdtA, CdtB, and CdtC proteins were purified by affinity chromatography using Ni Sepharose<sup>TM</sup> 6 Fast Flow (GE Healthcare Life Science, Pittsburgh, PA, USA). Purified recombinant proteins were confirmed by SDS-PAGE and Western blot analyses. The three subunits were reconstituted in complete CDT at 25&#x000b0;C for 1&#x02009;h for subsequent experiments.</p></sec><sec disp-level="2" id="s0002-s2006"><title>Flow cytometry</title><p>Cells were pre-seeded in 6-well plates (1&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells) for 12&#x02009;h and treated with different doses (0, 5, 50, or 500&#x02009;ng/mL) of CDT for 36&#x02009;h. After collection and washing twice with cold PBS, the cells were stained using the Annexin V-FITC/PI Apoptosis Assay Kit (4A Biotech, Beijing, China), according to the manufacturer&#x02019;s instructions. Stained cells were analysed with a BD FACSVerse<sup>TM</sup> flow cytometer (BD Biosciences, San Jose, CA, USA), and data were processed using FlowJo software (Ashland, Oregon, USA).</p></sec><sec disp-level="2" id="s0002-s2007"><title>qRT-PCR</title><p>Total RNA was extracted using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA). The isolated mRNA was converted to cDNA using a Reverse Transcription Kit (Vazyme Biotech, Nanjing, Jiangsu, China) according to the manufacturer&#x02019;s instructions. The qRT-PCR reactions were performed using 2&#x02009;&#x000d7;&#x02009;AceQ&#x000ae; qPCR SYBR&#x000ae; Green Master Mix (Vazyme Biotech, Nanjing, Jiangsu, China) and appropriate primers (<xref rid="t0002" ref-type="table">Table 2</xref>). The expression levels of the target genes were normalized using GAPDH as an internal reference and were calculated using the 2<sup>&#x02013;&#x00394;&#x00394;Ct</sup> method [<xref rid="cit0036" ref-type="bibr">36</xref>]. Data are presented as mean&#x02009;&#x000b1;&#x02009;SD from three independent assays.<table-wrap position="float" id="t0002"><label>Table 2.</label><caption><p>Gene-specific primers used in this study.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*" align="left"/><col width="1*" align="left"/><col width="1*" align="left"/><col width="1*" align="center"/><col width="1*" align="center"/></colgroup><thead><tr><th align="left">Gene</th><th align="center">Primer designation</th><th align="center">Nucleotide sequence (5&#x002b9;&#x02013;3&#x002b9;)</th><th align="center">Size of PCR product (bp)</th><th align="center">GenBank accession number</th></tr></thead><tbody><tr><td rowspan="2" align="left"><italic toggle="yes">GAPDH</italic></td><td align="left">GAPDH-F</td><td align="left">CACAGTCAAGGCGGAGAAC</td><td rowspan="2" align="center">106</td><td rowspan="2" align="center">NM_001206359.1</td></tr><tr><td align="left">GAPDH-R</td><td align="left">CGTAGCACCAGCATCAC</td></tr><tr><td rowspan="2" align="left"><italic toggle="yes">BAX</italic></td><td align="left">BAX-F</td><td align="left">TTTGCTTCAGGGTTTCATCCA</td><td rowspan="2" align="center">114</td><td rowspan="2" align="center">XM_003127290.5</td></tr><tr><td align="left">BAX-R</td><td align="left">AGACACTCGCTCAACTTCTTG</td></tr><tr><td rowspan="2" align="left"><italic toggle="yes">P53</italic></td><td align="left">p53-F</td><td align="left">CACGAACTGGCTGGATGA</td><td rowspan="2" align="center">170</td><td rowspan="2" align="center">NM_213824.3</td></tr><tr><td align="left">P53-R</td><td align="left">GGAACCCTAGACGGAAATCA</td></tr><tr><td rowspan="2" align="left"><italic toggle="yes">Bcl-2</italic></td><td align="left">Bcl-2-F</td><td align="left">GCAGGTATTGAACGAACTC</td><td rowspan="2" align="center">103</td><td rowspan="2" align="center">NM_214285.1</td></tr><tr><td align="left">Bcl-2-R</td><td align="left">CTCCTTGTCTACGCTCTC</td></tr><tr><td rowspan="2" align="left"><italic toggle="yes">LRRC8A</italic></td><td align="left">LRRC8A-F</td><td align="left">CCCAAGCTTATGATTCCGGTGACGGAGC</td><td rowspan="2" align="center">2,430</td><td rowspan="2" align="center">XM_001928850.6</td></tr><tr><td align="left">LRRC8A-R</td><td align="left">CCGGAATTCGGCCTGCTCCTTGTCG</td></tr></tbody></table></table-wrap></p></sec><sec disp-level="2" id="s0002-s2008"><title>Western blot</title><p>Cells were lysed by cell lysis buffer for Western blot (Beyotime, Shanghai, China) and then separated by SDS-PAGE (12.5%). The separated proteins were transferred to 0.45&#x02009;&#x003bc;m polyvinylidene fluoride (PVDF) membranes (Millipore, Billerica, MA, USA), followed by blocking in 5% skimmed milk for 1&#x02009;h at room temperature. The membranes were incubated with antibodies targeting p53, p-p53, BAX, Bcl-2, GAPDH, or LRRC8A at a dilution of 1:1,000 at 4&#x000b0;C overnight and then incubated with HRP-conjugated secondary antibodies at room temperature for 2&#x02009;h. The results of Western blot were densitometrically quantified and analysed using the ImageJ software (Bethesda, MD, United States, USA).</p></sec><sec disp-level="2" id="s0002-s2009"><title>Caspase-3 activity assay</title><p>Caspase-3 activity was determined by the cleavage of N-Acetyl-Asp-Glu-Val-Asp <italic toggle="yes">p</italic>-nitroanilide (Ac-DEVD-<italic toggle="yes">p</italic>NA) to produce yellow <italic toggle="yes">p</italic>-nitroaniline (<italic toggle="yes">p</italic>NA), and the fluorescence intensity was measured at 405&#x02009;nm for excitation. Caspase-3 activity was measured using a Caspase-3 Activity Assay Kit (Beyotime, Shanghai, China) according to the manufacturer&#x02019;s instructions.</p></sec><sec disp-level="2" id="s0002-s2010"><title>CRISPR/Cas9-mediated knockout and siRNA-mediated knockdown</title><p>In this study, CRISPR/Cas9 technology was used to generate LRRC8A-knockout cell lines. In our experiment, two guide RNAs (gRNA), 5&#x002b9;-CACCGTCCTGCAACGACTCGTTCCG-3&#x002b9; and 5&#x002b9;-CACCGTGCCCGTAGTTCATGCTGGA-3&#x002b9; to target LRRC8A, were respectively cloned into the gRNA-expression plasmid pCMV-Cas9-Puro (YSY Biotech, Nanjing, Jiangsu, China) before the protospacer adjacent motif (PAM). Two micrograms of pCMV-Cas9-Puro plasmid was transfected into 1.5&#x02009;&#x000d7;&#x02009;10<sup>6</sup> NPTr cells using the JetPRIME&#x000ae; Versatile DNA Transfection Reagent (Polyplus-transfection, Illkirch, Strasbourg, France) according to the manufacturer&#x02019;s instructions. Cells were selected with 2.5&#x02009;&#x003bc;g/mL puromycin for approximately 5&#x02013;7&#x02009;days after transfection for 48&#x02009;h. The gRNA-expressing cells were trypsinized, counted, and cultured in 96-well plates at a density of approximately one cell per well. Single clones were then cultured for 10&#x02013;14&#x02009;days or longer. The correct construction of the knockout cell lines was confirmed by DNA sequencing.</p><p>For siRNA knockdown, two specific siRNAs (5&#x002b9;-GGUACAACCACAUCGCCUA-3&#x002b9; and 5&#x002b9;-AGUACGACCUGGACCGACA-3&#x002b9;) (GenePharma, Wuhan, Hubei, China) were used to transiently knockdown LRRC8A expression; the sequences were designed according to a previous study [<xref rid="cit0025" ref-type="bibr">25</xref>]. The 25&#x02009;&#x003bc;M LRRC8A siRNA and scramble siRNA were transfected into 6-well plates (1.5&#x02009;&#x000d7;&#x02009;10<sup>6</sup> NPTr cells) using the JetPRIME&#x000ae; Versatile siRNA Transfection Reagent (Polyplus-transfection, Illkirch, Strasbourg, France), according to the manufacturer&#x02019;s instructions. Twenty-four hours after transfection, the cells were used for further experiments, and the knockdown efficiency of <italic toggle="yes">LRRC8A</italic> was measured using qRT-PCR.</p></sec><sec disp-level="2" id="s0002-s2011"><title>Statistical analysis</title><p>Data were compared by one-way or two-way ANOVA using GraphPad Prism version 8.0 (San Diego, CA, United States). All results are expressed as the mean&#x02009;&#x000b1;&#x02009;SEM from at least three replicates for each experiment. *<italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.05, considered statistically significant.</p></sec></sec><sec disp-level="1" id="s0003"><title>Results</title><sec disp-level="2" id="s0003-s2001"><title><italic toggle="yes">G. parasuis</italic> CDT is cytotoxic to NPTr cells</title><p>The CDT secreted by <italic toggle="yes">G. parasuis</italic>, which is an opportunistic pathogen, is less conserved than CDTs secreted by other pathogenic bacteria, with amino acid identities of 30.92%, 32.78%, 32.92%, 33.76%, 38.1%, and 48.8% in <italic toggle="yes">C. jejuni</italic>, <italic toggle="yes">Shigella dysenteriae</italic>, <italic toggle="yes">E. coli</italic>, <italic toggle="yes">Helicobacter hepaticus</italic>, <italic toggle="yes">A. actinomycetemcomitans</italic>, and <italic toggle="yes">H. ducreyi</italic>, respectively (<xref rid="f0001" ref-type="fig">Figure 1</xref>). Although CDT produced by several pathogenic bacteria has been proven to induce apoptosis in target cells, it is not clear how they interact with epithelial cells to break through the respiratory barrier. To investigate the cytotoxicity of <italic toggle="yes">G. parasuis</italic> CDT in NPTr cells, three CDT subunits, CdtA, CdtB, and CdtC, were expressed and purified. NPTr cells were then stimulated with recombinant proteins CdtA, CdtB, CdtC, holotoxin CdtABC (500&#x02009;ng/mL), 100 MOI of live <italic toggle="yes">G. parasuis</italic> wild-type (WT) strain, and 100 MOI of live CDT-deficient mutant strain of <italic toggle="yes">G. parasuis</italic> for 36&#x02009;h. As shown in <xref rid="f0002" ref-type="fig">Figure 2a</xref>, CdtABC and <italic toggle="yes">G. parasuis</italic> WT strain treatments increased the level of &#x003b3;H2AX, a DNA damage marker, in NPTr cells, when compared to individual subunit and <italic toggle="yes">G. parasuis</italic> mutant strain treatments. Additionally, CCK-8 and LDH release assays were performed to evaluate the cytotoxicity of <italic toggle="yes">G. parasuis</italic> CdtABC in NPTr cells. The results showed that cell viability was attenuated and the release of LDH was significantly increased in NPTr cells exposed to CdtABC and <italic toggle="yes">G. parasuis</italic> WT strain when compared to individual subunits and <italic toggle="yes">G. parasuis</italic> mutant strain (<xref rid="f0002" ref-type="fig">Figure 2b,c</xref>). Collectively, these data reveal that <italic toggle="yes">G. parasuis</italic> CdtABC is cytotoxic to NPTr cells.
<fig position="float" id="f0001" fig-type="figure"><label>Figure 1.</label><caption><p>Sequence alignment between CDT holotoxin from <italic toggle="yes">A. actinomycetemcomitans, H. ducreyi, G. parasuis, S. dysenteriae, E. coli, C. jejuni</italic>, and <italic toggle="yes">H. hepaticus</italic>. the alignment was generated using ClustalW2 algorithm and presented using ESPript 3.0 (<ext-link xlink:href="http://espript.Ibcp.fr/ESPript/cgibin/ESPript.Cgi" ext-link-type="uri">http://espript.Ibcp.fr/ESPript/cgibin/ESPript.Cgi</ext-link>). Identical residues are indicated by the dark red background and conserved residues are in red text.</p></caption><alternatives><graphic xlink:href="KVIR_A_2287339_F0001_OC" content-type="color" specific-use="web-only" position="float"/><graphic xlink:href="KVIR_A_2287339_F0001_PB" content-type="black-white" specific-use="print-only" position="float"/></alternatives></fig>
<fig position="float" id="f0002" fig-type="figure"><label>Figure 2.</label><caption><p><italic toggle="yes">G. parasuis</italic> CdtABC induces DNA double-strand breaks (DSB), cell death and inhibits cell viability in NPTr cells. NPTr cells were treated with 500&#x02009;ng/mL <italic toggle="yes">G. parasuis</italic> CdtA, CdtB, CdtC, CdtABC, 100 MOI of live <italic toggle="yes">G. parasuis</italic> WT strain (<italic toggle="yes">G. parasuis</italic>), and 100 MOI of live <italic toggle="yes">G. parasuis</italic> mutant strain (<italic toggle="yes">G. parasuis</italic> mut) for 36&#x02009;h. (A) DNA damage marker &#x003b3;H2AX was measured using immunofluorescence microscopy. Scale bar 100&#x02009;&#x003bc;m. (B, C) after treated with <italic toggle="yes">G. parasuis</italic> CdtA, CdtB, CdtC, CdtABC, live <italic toggle="yes">G. parasuis</italic> WT strain, and live <italic toggle="yes">G. parasuis</italic> mutant strain, cell viability and LDH release were measured using CCK-8 and LDH release assay (<italic toggle="yes">n</italic>&#x02009;=&#x02009;3).</p></caption><alternatives><graphic xlink:href="KVIR_A_2287339_F0002_OC" content-type="color" specific-use="web-only" position="float"/><graphic xlink:href="KVIR_A_2287339_F0002_PB" content-type="black-white" specific-use="print-only" position="float"/></alternatives></fig></p></sec><sec disp-level="2" id="s0003-s2002"><title><italic toggle="yes">G. parasuis</italic> CDT induces apoptosis in NPTr cells via p53-dependent pathway</title><p>NPTr cells were stimulated with CdtABC (0, 5, 50, or 500&#x02009;ng/mL) for 36&#x02009;h. The apoptotic effect of CdtABC was quantified using Annexin V-FITC/PI staining. As shown in <xref rid="f0003" ref-type="fig">Figure 3a</xref>, the apoptotic effect (indicated by the percentage of apoptotic cells) induced by CdtABC was significantly increased in a concentration-dependent manner. The activity of the apoptosis factor caspase-3 was determined to confirm its effect in NPTr cells. We found that CdtABC treatment enhanced the activity of caspase-3 in a concentration-dependent manner compared to untreated cells (<xref rid="f0003" ref-type="fig">Figure 3b</xref>). In the process of DNA damage response upon CdtABC stimulation, activated ataxia-telangiectasia-mutated (ATM) and ataxia telangiectasia and Rad3-related (ATR) proteins phosphorylate a variety of substrates, including p53. To examine the involvement of the p53 pathway in this process, the mRNA and protein levels of downstream apoptotic genes, including <italic toggle="yes">p53</italic>, <italic toggle="yes">p-p53</italic>, <italic toggle="yes">BAX</italic>, and <italic toggle="yes">Bcl-2</italic> were analysed using quantitative real-time PCR (qRT-PCR) and Western blot. Our results showed that the expression of <italic toggle="yes">p-p53, p53</italic>, and <italic toggle="yes">BAX</italic> was upregulated, whereas <italic toggle="yes">Bcl-2</italic> was downregulated in NPTr cells (<xref rid="f0003" ref-type="fig">Figure 3c</xref>). Moreover, the conclusions drawn by Western blot were consistent with the qRT-PCR results (<xref rid="f0003" ref-type="fig">Figure 3d,e</xref>). To demonstrate that p53 is directly involved in <italic toggle="yes">G. parasuis</italic> CdtABC-induced apoptosis, NPTr were exposed to <italic toggle="yes">G. parasuis</italic> CdtABC (500&#x02009;ng/mL) with or without pifithrin-&#x003b1; (40&#x02009;&#x003bc;M) (PFT-&#x003b1;), a specific p53 blocker. Flow cytometry analysis revealed that the percentage of CdtABC-induced apoptotic cells significantly decreased after pretreatment with PFT-&#x003b1; (<xref rid="f0003" ref-type="fig">Figure 3f</xref>). Furthermore, the activity of caspase-3, and the expression level of p53 and BAX also decreased, whereas the expression level of Bcl-2 increased (<xref rid="f0003" ref-type="fig">Figure 3g,h</xref>). These data suggest that CdtABC treatment activates the p53-dependent pathway and ultimately induces apoptosis in NPTr cells.
<fig position="float" id="f0003" fig-type="figure"><label>Figure 3.</label><caption><p><italic toggle="yes">G. parasuis</italic> CdtABC induces apoptosis in NPTr cells <italic toggle="yes">via</italic> p53-dependent pathway. NPTr cells were treated with different concentrations (0, 5, 50, or 500&#x02009;ng/mL) of <italic toggle="yes">G. parasuis</italic> CdtABC for 36&#x02009;h. (a) the percentage of apoptotic cells in NPTr cells was measured using flow cytometry. The doxorubicin was used as a positive control, while DMSO and BSA were used as negative controls. (b) activity of apoptosis factor caspase-3 was measured in NPTr cells. (c) the mRNA levels of p53, BAX, and Bcl-2 in NPTr cells were analyzed using qRT-PCR after treatment with CdtABC. (d, e) expression of p-p53, p53, BAX, and Bcl-2 in NPTr cells was measured after CdtABC stimulation. To reveal that NPTr apoptosis was induced by <italic toggle="yes">G. parasuis</italic> CdtABC <italic toggle="yes">via</italic> a p53-dependent pathway, NPTr cells were exposed to <italic toggle="yes">G. parasuis</italic> CdtABC (500&#x02009;ng/mL) with or without pifithrin-&#x003b1; (40&#x02009;&#x003bc;M), a specific p53 blocker. (f) the percentage of apoptotic cells in NPTr cells was measured using flow cytometry. (g) activity of caspase-3 was measured. (H) expression of p53, BAX and Bcl-2 in NPTr cells was examined after CdtABC stimulation. Band intensity ratios were calculated from Western blot and values give relative to control cells. The statistical significance of the indicated <italic toggle="yes">P</italic> values was determined as: *<italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.001. All data shown are representative of at least three independent experiments.</p></caption><alternatives><graphic xlink:href="KVIR_A_2287339_F0003_OC" content-type="color" specific-use="web-only" position="float"/><graphic xlink:href="KVIR_A_2287339_F0003_PB" content-type="black-white" specific-use="print-only" position="float"/></alternatives></fig></p></sec><sec disp-level="2" id="s0003-s2003"><title>VRAC blockers inhibit CDT-induced apoptosis in NPTr cells</title><p>Cell volume changes during cell death with isosmotic cell shrinkage, a process called AVD, is a marker of apoptosis [<xref rid="cit0021" ref-type="bibr">21</xref>]. In recent research, VRAC-mediated AVD has been shown to be related to the anti-apoptotic effect of cancer cells towards the anticancer drug cisplatin, a DNA-damaging agent, as it plays a significant role in the intrinsic apoptotic pathway, including the expression of BAX/Bcl-2 and activation of caspase-9/3/7 [<xref rid="cit0037" ref-type="bibr">37</xref>]. Thus, it is plausible to speculate a connection between CDT-induced apoptosis and VRAC-mediated AVD. Therefore, we hypothesized that VRAC is associated with CDT-triggered apoptosis. In the present study, NPTr cells were pre-treated with the VRAC blockers PPQ-102 or NS3728 for 2&#x02009;h, followed by treatment with 500&#x02009;ng/mL CDT. We found that treatment with either PPQ-102 or NS3728 inhibited CDT-induced apoptosis, as shown by the flow cytometry analysis of Annexin V-FITC/PI staining (<xref rid="f0004" ref-type="fig">Figure 4a</xref>). In addition, the presence of either PPQ-102 or NS3728 decreased the activity of apoptosis factor caspase-3 in NPTr cells (<xref rid="f0004" ref-type="fig">Figure 4b</xref>). To further confirm the role of VRAC, protein levels of p-p53, p53, and BAX were measured. As expected, the expression levels of p-p53, p53, and BAX markedly decreased after priming with either PPQ-102 or NS3728 in NPTr cells (<xref rid="f0004" ref-type="fig">Figure 4c</xref>). Together, these results indicate that the VRAC blockers PPQ-102 and NS3728 reduce CDT-induced apoptosis in NPTr cells.
<fig position="float" id="f0004" fig-type="figure"><label>Figure 4.</label><caption><p>VRAC blockers inhibit <italic toggle="yes">G. parasuis</italic> CdtABC-induced apoptosis in NPTr cells. NPTr cells were pre-treated with 30&#x02009;&#x003bc;M PPQ-102 or 10&#x02009;&#x003bc;M NS3728 for 2&#x02009;h and subsequently exposed to 500&#x02009;ng/mL CdtABC for another 36&#x02009;h. (a) the percentage of apoptotic cells in NPTr was measured using flow cytometry. (b) after CdtABC treatment, the activity of the apoptosis factor caspase-3 was measured. (c) the expression of p-p53, p53, and BAX protein relative to GAPDH in NPTr cells was analyzed using Western blot. Band intensity ratios were calculated from Western blot, and values are given relative to control cells. The statistical significance of the indicated <italic toggle="yes">P</italic> values was determined as: *<italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.001. All data shown are representative of at least three independent experiments.</p></caption><alternatives><graphic xlink:href="KVIR_A_2287339_F0004_OC" content-type="color" specific-use="web-only" position="float"/><graphic xlink:href="KVIR_A_2287339_F0004_PB" content-type="black-white" specific-use="print-only" position="float"/></alternatives></fig></p></sec><sec disp-level="2" id="s0003-s2004"><title>Transient knockdown of LRRC8A reduces CDT-induced apoptosis in NPTr cells</title><p>VRAC blockers have been reported to exhibit no ability to selectively inhibit a single family of chloride channels, leading to inhibition of other anion channels [<xref rid="cit0038" ref-type="bibr">38</xref>]. LRRC8A has been identified as an essential component of the VRAC, contributing to a decrease in the regulatory volume [<xref rid="cit0025" ref-type="bibr">25</xref>]. Therefore, we employed siRNA technology to knock down the expression of <italic toggle="yes">LRRC8A</italic> (the knockdown efficiency was measured using qRT-PCR 24&#x02009;h post-transfection) to explore the indispensability of LRRC8A in CDT-induced apoptosis. An analysis of <italic toggle="yes">LRRC8A</italic> mRNA levels using qRT-PCR showed that NPTr cells transfected with <italic toggle="yes">LRRC8A</italic> siRNA exhibited more than 75% reduction in the expression of <italic toggle="yes">LRRC8A</italic>, compared with the scramble siRNA transfection group, which showed no obvious difference from the control group (<xref rid="f0005" ref-type="fig">Figure 5a</xref>). CDT-induced apoptosis was largely attenuated in <italic toggle="yes">LRRC8A</italic>-silenced cells, as evidenced by the decreased caspase-3 activation (<xref rid="f0005" ref-type="fig">Figure 5b</xref>). Meanwhile, the next series of experiments in control NPTr cells revealed enhanced expression levels of p53, p-p53, and BAX after CDT stimulation. However, this increase was severely suppressed in <italic toggle="yes">LRRC8A</italic>-silenced cells (<xref rid="f0005" ref-type="fig">Figure 5c</xref>). These data suggest that <italic toggle="yes">LRRC8A</italic> knockdown in NPTr reduces CDT-induced apoptosis.
<fig position="float" id="f0005" fig-type="figure"><label>Figure 5.</label><caption><p>LRRC8A knockdown reduces <italic toggle="yes">G. parasuis</italic> CdtABC-induced NPTr apoptosis. NPTr cells were pre-treated with 25&#x02009;nM LRRC8A siRNA or 25&#x02009;nM scramble siRNA for 24&#x02009;h prior to expose to 500&#x02009;ng/mL CdtABC for another 36&#x02009;h. (a) the interference efficiency of LRRC8A siRNA was measured using qRT-PCR. Scramble siRNA serves as a negative control. (b) the activity of apoptosis factor caspase-3 was measured in NPTr cells. (c) expression of p-p53, p53, and BAX relative to GAPDH in NPTr cells were analyzed using Western blot. Band intensity ratios were calculated from Western blot and values give relative to control cells. The statistical significance of the indicated <italic toggle="yes">P</italic> values was determined as: *<italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.001. All data shown are representative of at least three independent experiments.</p></caption><graphic xlink:href="KVIR_A_2287339_F0005_B" content-type="black-white" position="float"/></fig></p></sec><sec disp-level="2" id="s0003-s2005"><title>Knockout of <italic toggle="yes">LRRC8A</italic> reduces CDT-induced apoptosis in NPTr cells</title><p>To rule out the potential off-target effects of siRNA, <italic toggle="yes">LRRC8A</italic> gene was knocked out in NPTr cells using CRISPR/Cas9 technology (<xref rid="f0006" ref-type="fig">Figure 6a</xref>). The apoptotic effect of CDT was further quantified using Annexin V-FITC/PI staining assays. In line with the results of siRNA knockdown, flow cytometry analysis revealed that knockout of <italic toggle="yes">LRRC8A</italic> resulted in a significant decrease in the percentage of cell death compared to WT cells in response to CDT (<xref rid="f0006" ref-type="fig">Figure 6b</xref>). Meanwhile, the activity of caspase-3, which was enhanced in wild-type cells after CDT treatment, was attenuated in <italic toggle="yes">LRRC8A</italic><sup><italic toggle="yes">&#x02013;/&#x02013;</italic></sup> cells (<xref rid="f0006" ref-type="fig">Figure 6c</xref>). In addition, we found that the expression of p-p53, p53, and BAX proteins was significantly reduced in <italic toggle="yes">LRRC8A</italic><sup><italic toggle="yes">&#x02013;/&#x02013;</italic></sup> NPTr cells compared to that in WT cells after CDT treatment for 36&#x02009;h (<xref rid="f0006" ref-type="fig">Figure 6d</xref>). These data further demonstrate that the absence of <italic toggle="yes">LRRC8A</italic> reduces CDT-triggered apoptosis in NPTr cells.
<fig position="float" id="f0006" fig-type="figure"><label>Figure 6.</label><caption><p>LRRC8A knockout reduces <italic toggle="yes">G. parasuis</italic> CdtABC-induced NPTr apoptosis. wild-type NPTr cells or <italic toggle="yes">LRRC8A</italic><sup>&#x02013;/&#x02013;</sup> NPTr cells were treated with CdtABC for 36&#x02009;h. (a) <italic toggle="yes">LRRC8A</italic><sup>&#x02013;/&#x02013;</sup> NPTr cell line was established by CRISPR/Cas9-mediated genome editing. Two gRNAs matching the sequences flanking the exon 3 were used to achieve deletion of a large genomic fragment containing the exon 3. The upper panel shows the relevant part of LRRC8A genome structure, and the lower panel shows the sequences of the targeted region. (b) the percentage of apoptotic cells in NPTr cells was measured using flow cytometry. (c) the activity of apoptosis factor caspase-3 was measured in NPTr cells. (d) expression of p-p53, p53, and BAX relative to GAPDH in wild-type NPTr cells and <italic toggle="yes">LRRC8A</italic><sup>&#x02013;/&#x02013;</sup> NPTr cells were analyzed using Western blot. GAPDH expression is the loading control. The statistical significance of the indicated <italic toggle="yes">P</italic> values was determined as: *<italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.001. All data shown are representative of at least three independent experiments.</p></caption><alternatives><graphic xlink:href="KVIR_A_2287339_F0006_OC" content-type="color" specific-use="web-only" position="float"/><graphic xlink:href="KVIR_A_2287339_F0006_PB" content-type="black-white" specific-use="print-only" position="float"/></alternatives></fig></p></sec><sec disp-level="2" id="s0003-s2006"><title>Re-expression of <italic toggle="yes">sus scrofa LRRC8A</italic> in <italic toggle="yes">LRRC8A</italic><sup>&#x02013;/&#x02013;</sup>
<italic toggle="yes">NPTr</italic> cells restores CDT-induced apoptosis</title><p>To further investigate the role of LRRC8A, a pcDNA3.1-LRRC8A plasmid was constructed to restore the expression of LRRC8A. A stable cell line, called &#x0201c;LRRC8A-RE&#x0201d; was established by puromycin selection (<xref rid="f0007" ref-type="fig">Figure 7a</xref>). The efficiency of LRRC8A rescue was analysed <italic toggle="yes">via</italic> qRT-PCR after the knockout cell lines were transfected with the plasmid. The qRT-PCR assay results indicated that <italic toggle="yes">LRRC8A</italic> mRNA levels increased by more than 6-fold compared to those in WT cells (<xref rid="f0007" ref-type="fig">Figure 7b</xref>). Compared with knockout cells, the activity of the apoptosis factor caspase-3 was remarkably augmented in LRRC8A-RE cells (<xref rid="f0007" ref-type="fig">Figure 7c</xref>). In contrast to the effect of <italic toggle="yes">LRRC8A</italic> knockout, re-expression of LRRC8A significantly enhanced the expression of p-p53, p53, and BAX (<xref rid="f0007" ref-type="fig">Figure 7d</xref>). Taken together, re-expression of LRRC8A in <italic toggle="yes">LRRC8A</italic><sup>&#x02013;<italic toggle="yes">/</italic>&#x02013;</sup> NPTr cells restore CDT-induced apoptosis in NPTr cells, which could be attributed to regaining sensitivity to CDT in <italic toggle="yes">LRRC8A</italic><sup>&#x02013;<italic toggle="yes">/</italic>&#x02013;</sup> NPTr cells when complemented with <italic toggle="yes">Sus scrofa</italic> LRRC8A.
<fig position="float" id="f0007" fig-type="figure"><label>Figure 7.</label><caption><p>Re-expression of <italic toggle="yes">Sus scrofa</italic> LRRC8A in <italic toggle="yes">LRRC8A</italic><sup>&#x02013;/&#x02013;</sup> NPTr cells restores CdtABC-induced apoptosis. wild-type NPTr cells, <italic toggle="yes">LRRC8A</italic><sup>&#x02013;/&#x02013;</sup> NPTr cells, and LRRC8A rescued cells were treated with CdtABC for 36&#x02009;h. (a) identification of LRRC8A and pcDNA3.1-LRRC8A using PCR. (b) <italic toggle="yes">Sus scrofa</italic> LRRC8A was stably expressed in the knockout cells and its expression levels were measured using qRT-PCR. (c) the activity of apoptosis factor caspase-3 was measured in wild-type NPTr cells, <italic toggle="yes">LRRC8A</italic><sup>&#x02013;/&#x02013;</sup> NPTr cells, and LRRC8A rescued cells. (d) expression of p-p53, p53, and BAX relative to GAPDH in wild-type NPTr cells, <italic toggle="yes">LRRC8A</italic><sup>&#x02013;/&#x02013;</sup> NPTr cells, and LRRC8A rescued cells. Band intensity ratios were calculated from Western blot and values give relative to control cells. The statistical significance of the indicated <italic toggle="yes">P</italic> values was determined as: *<italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.001. All data shown are representative of at least three independent experiments.</p></caption><graphic xlink:href="KVIR_A_2287339_F0007_B" content-type="black-white" position="float"/></fig></p></sec></sec><sec disp-level="1" id="s0004"><title>Discussion</title><p>The aim of this study was to explore the influence of <italic toggle="yes">G. parasuis</italic> CDT on NPTr and the role of LRRC8A in this process. Two main findings drawn from our study are as follows: (i) <italic toggle="yes">G. parasuis</italic> CDT could induce NPTr apoptosis <italic toggle="yes">via</italic> a p53-dependent pathway, suggesting that this pathogen compromises the integrity of the respiratory tract epithelium; (ii) downregulation of LRRC8A attenuates CDT-induced apoptosis, whereas re-expression of LRRC8A in <italic toggle="yes">LRRC8A</italic><sup>&#x02013;/&#x02013;</sup> cells effectively restores apoptosis, indicating that LRRC8A is involved in the regulation of apoptosis. These results support the model shown in <xref rid="f0008" ref-type="fig">Figure 8</xref>.
<fig position="float" id="f0008" fig-type="figure"><label>Figure 8.</label><caption><p>The important role of LRRC8A plays in <italic toggle="yes">G. parasuis</italic> CdtABC-induced apoptosis. the dash line indicates that CdtABC is internalized into the cell followed by the relocation of CdtB to the nucleus through an unknown pathway. As possessing DNase activity, CdtB brings about DNA double-strand breaks (DSB), which leads to DNA damage response. Induction of apoptosis <italic toggle="yes">via</italic> p53 pathway is generally elicited by CdtABC exposure as DNA damage. Activation of p53 decreased the expression of anti-apoptosis factor Bcl-2 and increased the expression of pro-apoptosis factor BAX, leading to increased mitochondrial outer-membrane permeabilization, cytochrome <italic toggle="yes">c</italic> release, activation of caspase-9 and subsequent executer caspase-3. LRRC8A is also activated by pro-apoptotic stimuli. Activation of LRRC8A triggers cell shrinkage (apoptotic volume decrease) as Cl<sup>&#x02013;</sup> and osmolyte efflux through CdtABC-activated VRAC, which is essential for the phosphorylation of p53 and the progression of apoptosis. Thus, LRRC8A promotes the pro-apoptosis effect of CdtABC.</p></caption><alternatives><graphic xlink:href="KVIR_A_2287339_F0008_OC" content-type="color" specific-use="web-only" position="float"/><graphic xlink:href="KVIR_A_2287339_F0008_PB" content-type="black-white" specific-use="print-only" position="float"/></alternatives></fig></p><p>CDT plays a significant role in bacterial pathogenicity with the ability of invading the immune system and destroying the epithelial barrier [<xref rid="cit0008" ref-type="bibr">8</xref>,<xref rid="cit0009" ref-type="bibr">9</xref>]. CDT is composed of three subunits, CdtA, CdtB, and CdtC, with CdtB possessing DNase activity and a function that brings about a DNA damage response (DDR), which represents DNA single-strand breaks (SSB) or double-strand breaks (DSB) [<xref rid="cit0039" ref-type="bibr">39</xref>]. DDR is characterized by irreversible cell cycle arrest in the G2/M phase and eventual apoptosis [<xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0040" ref-type="bibr">40</xref>]. The virulent strains of <italic toggle="yes">G. parasuis</italic> exhibit strong colonization and pathogenicity in the lungs and trachea [<xref rid="cit0041" ref-type="bibr">41</xref>]. However, the role of apoptosis in NPTr cells in response to CDT treatment remains unclear.</p><p>The p53 signalling pathway is vital for regulating the cell cycle, DNA damage, and mitochondrial pathway of apoptosis [<xref rid="cit0014" ref-type="bibr">14</xref>]. The results of the present study suggest that NPTr cells exposed to 500&#x02009;ng/mL CDT showed upregulated expression of p-p53, p53, and BAX, accompanied by downregulation of Bcl-2, as well as increased activity of apoptosis factor caspase-3, implying that <italic toggle="yes">G. parasuis</italic> CDT-induced apoptosis in NPTr cells depends on the p53-mediated mitochondrial pathway. Intriguingly, recent studies have clearly demonstrated that the apoptotic pathway induced by CDT is not identical, depending on the bacterial strain and its target cells, although they exhibit similar activity to DNase. For example, CDT from <italic toggle="yes">H. ducreyi</italic> induces p53-independent apoptosis in ATM-deficient lymphoblasts [<xref rid="cit0008" ref-type="bibr">8</xref>], whereas apoptosis in pulmonary alveolar macrophage (PAM) cells and porcine kidney epithelial (PK-15) cells induced by <italic toggle="yes">H. parasuis</italic> CDT is p53-dependent [<xref rid="cit0042" ref-type="bibr">42</xref>]. A plausible explanation for this discrepancy may be that the role of p53 in CDT-induced apoptosis depends on the specific cell type and source of the toxin [<xref rid="cit0043" ref-type="bibr">43</xref>].</p><p>To the best of our knowledge, a major hallmark of apoptosis is normotonic shrinkage of cells, also known as apoptotic volume decrease (AVD), which is considered an early prerequisite for apoptotic events and precedes other apoptotic changes, such as caspase activation [<xref rid="cit0020" ref-type="bibr">20</xref>,<xref rid="cit0021" ref-type="bibr">21</xref>]. AVD is a dynamic process that is divided into AVD<sub>1</sub>, AVD<sub>T</sub>, and AVD<sub>2</sub>, which reflects a balance between intra- and extracellular osmotic pressure between pro-apoptotic and anti-apoptotic processes [<xref rid="cit0021" ref-type="bibr">21</xref>]. In recent research, VRAC was shown to be required for AVD, especially in the AVD<sub>1</sub> stage [<xref rid="cit0044" ref-type="bibr">44</xref>]. Inhibition of VRAC alleviates AVD and ultimately suppresses apoptosis [<xref rid="cit0021" ref-type="bibr">21</xref>]. As a core component of VRAC, LRRC8A participates in the regulation of chemotherapy resistance by influencing its anti-apoptotic activity. For example, S&#x000f8;rensen et al. [<xref rid="cit0037" ref-type="bibr">37</xref>] demonstrated that LRRC8A is associated with sensitivity to the anti-tumour drug cisplatin in several cell lines <italic toggle="yes">via</italic> affecting the AVD process and p53 activation. According to genome sequence alignment, <italic toggle="yes">Sus scrofa</italic> LRRC8A shares more than 99.34% amino acid sequence similarity with <italic toggle="yes">Homo sapiens</italic> and <italic toggle="yes">Mus musculus</italic>. Considering the high structural conservation of LRRC8A and the similarity of pro-apoptotic mechanisms between anti-tumour drugs and CDT, it is plausible to postulate that the function of LRRC8A might also be involved in CDT-induced apoptosis in NPTr cells. Therefore, we explored the functional significance of LRRC8A in CDT-induced apoptosis in NPTr cells. We demonstrated that inhibition of VRAC with either PPQ-102 or NS3728 in NPTr cells markedly reduced CDT-induced apoptosis <italic toggle="yes">via</italic> the p53/BAX/caspase-3 pathway. As the chemical blocker of VRAC usually inhibits other channels, attenuated apoptosis was confirmed by siRNA-mediated knockdown and CRISPR/Cas9-mediated LRRC8A deletion in NPTr cells. Conversely, re-expression of LRRC8A in <italic toggle="yes">LRRC8A</italic><sup>&#x02013;/&#x02013;</sup> NPTr cells re-established their sensitivity towards CDT, which confirms our conclusion to a high degree that CDT-induced apoptosis is correlated with the expression of LRRC8A. Notably, the effects of LRRC8A on different cell lines could be adverse. For example, LRRC8A is highly expressed in hepatocellular carcinoma tissues, which inhibits apoptosis and strengthens cell proliferation and migration while promoting apoptosis in glioblastoma, ovarian, and alveolar carcinoma cells [<xref rid="cit0031" ref-type="bibr">31</xref>,<xref rid="cit0037" ref-type="bibr">37</xref>,<xref rid="cit0045" ref-type="bibr">45</xref>]. The reason why LRRC8A plays opposing roles in different cell lines is unknown. A possible explanation may be that LRRC8A not only serves as a part of VRAC but also as a signal protein that regulates apoptosis by different mechanisms. Nevertheless, there are still some limitations to our study that require further investigation. First, although LRRC8A is involved in this process, its exact molecular mechanism remains unclear. On the one hand, activation of LRRC8A-containing transporter (VRAC) might contribute to AVD and p53 activation. On the other hand, LRRC8A has also been shown to be correlated with some signalling pathways, such as PKC&#x003b1;-LRRC8A-PI3K/AKT-p21 [<xref rid="cit0045" ref-type="bibr">45</xref>], which may be the underlying mechanism of LRRC8A in apoptosis as well. Second, VRAC can be activated not only by cell swelling or reduced intracellular ionic strength but also by other pro-apoptotic stimuli in the absence of cell swelling [<xref rid="cit0046" ref-type="bibr">46</xref>,<xref rid="cit0047" ref-type="bibr">47</xref>]. In the present study, we did not provide direct evidence for assessing VRAC activation in response to CDT. Additionally, to date, the researches for LRRC8A in apoptosis are focused on the mitochondria-dependent pathway. A myriad of experimental studies are still required to elucidate the exact mechanism and its role in the exogenous apoptotic pathway.</p></sec><sec disp-level="1" id="s0005"><title>Conclusion</title><p>Our research reveals that <italic toggle="yes">G. parasuis</italic> CDT induces apoptosis in NPTr cells by activating the p53 signalling pathway. Furthermore, LRRC8A, the core component of VRAC, is a crucial regulator of this process. Its downregulation and knockout reduce CDT-induced apoptosis in NPTr cells. Our findings imply that LRRC8A plays a central role CDT-induced apoptosis in <italic toggle="yes">G. parasuis</italic> and provide a light on its potential as an apoptosis effector or biomarker.</p></sec></body><back><sec sec-type="COI-statement" disp-level="1" id="s0006"><title>Disclosure statement</title><p>No potential conflict of interest was reported by the author(s).</p></sec><sec disp-level="1" id="s0007"><title>Author contribution</title><p>XC designed the experiments, supervised the study, edited the manuscript, and acquired funding. WM designed, performed experiments and drafted the manuscript. ZW, SW, JG and YL edited the manuscript. ZW and SW supplemented the experiments. WM, ZW, YL, HW, JS, and QC analysed the data and contributed reagents, materials, and analysis tools. YX and XX provided overall supervision. All authors have contributed to the manuscript and approved the submitted version.</p></sec><sec sec-type="data-availability" disp-level="1" id="s0008"><title>Data availability statement</title><p>The datasets generated for this study are available on request to the corresponding author.</p></sec><ref-list><title>References</title><ref id="cit0001"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Oliveira</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Pijoan</surname>
<given-names>C.</given-names></string-name></person-group>
<article-title><italic toggle="yes">Haemophilus parasuis</italic>: new trends on diagnosis, epidemiology and control</article-title>. <source>Vet Microbiol</source>. <year>2004</year>;<volume>99</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.vetmic.2003.12.001</pub-id><pub-id pub-id-type="pmid">15019107</pub-id>
</mixed-citation></ref><ref id="cit0002"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Boesze-Battaglia</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Dhingra</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Walker</surname>
<given-names>LM</given-names></string-name>, et al</person-group>. <article-title>Internalization and intoxication of human macrophages by the active subunit of the <italic toggle="yes">aggregatibacter actinomycetemcomitans</italic> cytolethal distending toxin is dependent upon cellugyrin (synaptogyrin-2)</article-title>. <source>Front Immunol</source>. <year>2020</year>;<volume>11</volume>:<fpage>1262</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2020.01262</pub-id><pub-id pub-id-type="pmid">32655562</pub-id>
</mixed-citation></ref><ref id="cit0003"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Friedrich</surname>
<given-names>AW</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bielaszewska</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>Cytolethal distending toxin in <italic toggle="yes">Escherichia coli</italic> O157: H7: spectrum of conservation, structure, and endothelial toxicity</article-title>. <source>J Clin Microbiol</source>. <year>2006</year>;<volume>44</volume>(<issue>5</issue>):<fpage>1844</fpage>&#x02013;<lpage>1846</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JCM.44.5.1844-1846.2006</pub-id><pub-id pub-id-type="pmid">16672418</pub-id>
</mixed-citation></ref><ref id="cit0004"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Boesze-Battaglia</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Walker</surname>
<given-names>LP</given-names></string-name>, et al</person-group>. <article-title>The active subunit of the cytolethal distending toxin, CdtB, derived from both <italic toggle="yes">Haemophilus ducreyi</italic> and <italic toggle="yes">Campylobacter jejuni</italic> exhibits potent phosphatidylinositol-3,4,5-triphosphate phosphatase activity</article-title>. <source>Front Cell Infect Microbiol</source>. <year>2021</year>;<volume>11</volume>:<fpage>664221</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2021.664221</pub-id><pub-id pub-id-type="pmid">33854985</pub-id>
</mixed-citation></ref><ref id="cit0005"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gargi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Tamilselvam</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Powers</surname>
<given-names>B</given-names></string-name>, et al</person-group>. <article-title>Cellular interactions of the cytolethal distending toxins from <italic toggle="yes">Escherichia coli</italic> and <italic toggle="yes">Haemophilus ducreyi</italic></article-title>. <source>J Biol Chem</source>. <year>2013</year>;<volume>288</volume>(<issue>11</issue>):<fpage>7492</fpage>&#x02013;<lpage>7505</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M112.448118</pub-id><pub-id pub-id-type="pmid">23306199</pub-id>
</mixed-citation></ref><ref id="cit0006"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kamei</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kawabata</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Asakura</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>A cytolethal distending toxin gene-based multiplex PCR assay for <italic toggle="yes">campylobacter jejuni</italic>, <italic toggle="yes">C. fetus</italic>, <italic toggle="yes">C. coli</italic>, <italic toggle="yes">C. upsaliensis</italic>, <italic toggle="yes">C. hyointestinalis</italic>, and <italic toggle="yes">C. lari hyointestinalis, and C. lari. Jpn</italic></article-title>. <source>J Infect Dis</source>. <year>2016</year>;<volume>69</volume>(<issue>3</issue>):<fpage>256</fpage>&#x02013;<lpage>258</lpage>. doi: <pub-id pub-id-type="doi">10.7883/yoken.JJID.2015.182</pub-id></mixed-citation></ref><ref id="cit0007"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shima</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Hinenoya</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Asakura</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>Molecular characterizations of cytolethal distending toxin produced by <italic toggle="yes">providencia alcalifaciens</italic> strains isolated from patients with diarrhea</article-title>. <source>Infect Immun</source>. <year>2012</year>;<volume>80</volume>(<issue>4</issue>):<fpage>1323</fpage>&#x02013;<lpage>1332</lpage>. doi: <pub-id pub-id-type="doi">10.1128/iai.05831-11</pub-id><pub-id pub-id-type="pmid">22252871</pub-id>
</mixed-citation></ref><ref id="cit0008"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cortes-Bratti</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Karlsson</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Lagerg&#x000e5;rd</surname>
<given-names>T</given-names></string-name>, et al</person-group>. <article-title>The <italic toggle="yes">Haemophilus ducreyi</italic> cytolethal distending toxin induces cell cycle arrest and apoptosis <italic toggle="yes">via</italic> the DNA damage checkpoint pathways</article-title>. <source>J Biol Chem</source>. <year>2001</year>;<volume>276</volume>(<issue>7</issue>):<fpage>5296</fpage>&#x02013;<lpage>5302</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M008527200</pub-id><pub-id pub-id-type="pmid">11076947</pub-id>
</mixed-citation></ref><ref id="cit0009"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Damek-Poprawa</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Haris</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Volgina</surname>
<given-names>A</given-names></string-name>, et al</person-group>. <article-title>Cytolethal distending toxin damages the oral epithelium of gingival explants</article-title>. <source>J Dent Res</source>. <year>2011</year>;<volume>90</volume>(<issue>7</issue>):<fpage>874</fpage>&#x02013;<lpage>879</lpage>. doi: <pub-id pub-id-type="doi">10.1177/0022034511403743</pub-id><pub-id pub-id-type="pmid">21471326</pub-id>
</mixed-citation></ref><ref id="cit0010"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pickett</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Cottle</surname>
<given-names>DL</given-names></string-name>, <string-name><surname>Pesci</surname>
<given-names>EC</given-names></string-name>, et al</person-group>. <article-title>Cloning, sequencing, and expression of the <italic toggle="yes">Escherichia coli</italic> cytolethal distending toxin genes</article-title>. <source>Infect Immun</source>. <year>1994</year>;<volume>62</volume>(<issue>3</issue>):<fpage>1046</fpage>&#x02013;<lpage>1051</lpage>. doi: <pub-id pub-id-type="doi">10.1128/iai.62.3.1046-1051.1994</pub-id><pub-id pub-id-type="pmid">8112838</pub-id>
</mixed-citation></ref><ref id="cit0011"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bezine</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Vignard</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Mirey</surname>
<given-names>G</given-names></string-name></person-group>. <article-title>The cytolethal distending toxin effects on mammalian cells: a DNA damage perspective</article-title>. <source>Cells</source>. <year>2014</year>;<volume>3</volume>(<issue>2</issue>):<fpage>592</fpage>&#x02013;<lpage>615</lpage>. doi: <pub-id pub-id-type="doi">10.3390/cells3020592</pub-id><pub-id pub-id-type="pmid">24921185</pub-id>
</mixed-citation></ref><ref id="cit0012"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jinadasa</surname>
<given-names>RN</given-names></string-name>, <string-name><surname>Bloom</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>Weiss</surname>
<given-names>RS</given-names></string-name>, et al</person-group>. <article-title>Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages</article-title>. <source>Microbiology</source>. <year>2011</year>;<volume>157</volume>(<issue>7</issue>):<fpage>1851</fpage>&#x02013;<lpage>1875</lpage>. doi: <pub-id pub-id-type="doi">10.1099/mic.0.049536-0</pub-id><pub-id pub-id-type="pmid">21565933</pub-id>
</mixed-citation></ref><ref id="cit0013"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Elwell</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Dreyfus</surname>
<given-names>LA</given-names></string-name></person-group>. <article-title>DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest</article-title>. <source>Mol Microbiol</source>. <year>2000</year>;<volume>37</volume>(<issue>4</issue>):<fpage>952</fpage>&#x02013;<lpage>963</lpage>. doi: <pub-id pub-id-type="doi">10.1046/j.1365-2958.2000.02070.x</pub-id><pub-id pub-id-type="pmid">10972814</pub-id>
</mixed-citation></ref><ref id="cit0014"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>X</given-names></string-name>, et al</person-group>. <article-title>Dysregulation of cells cycle and apoptosis in human induced pluripotent stem cells chondrocytes through p53 pathway by HT-2 toxin: an <italic toggle="yes">in vitro</italic> study</article-title>. <source>Front Genet</source>. <year>2021</year>;<volume>12</volume>:<fpage>677723</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fgene.2021.677723</pub-id><pub-id pub-id-type="pmid">34421989</pub-id>
</mixed-citation></ref><ref id="cit0015"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Helton</surname>
<given-names>ES</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>X</given-names></string-name></person-group>. <article-title>p53 modulation of the DNA damage response</article-title>. <source>J Cell Biochem</source>. <year>2007</year>;<volume>100</volume>(<issue>4</issue>):<fpage>883</fpage>&#x02013;<lpage>896</lpage>. doi: <pub-id pub-id-type="doi">10.1002/jcb.21091</pub-id><pub-id pub-id-type="pmid">17031865</pub-id>
</mixed-citation></ref><ref id="cit0016"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Green</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Llambi</surname>
<given-names>F</given-names></string-name></person-group>. <article-title>Cell death signaling</article-title>. <source>Cold Spring Harb Perspect Biol</source>. <year>2015</year>;<volume>7</volume>(<issue>12</issue>):<fpage>a006080</fpage>. doi: <pub-id pub-id-type="doi">10.1101/cshperspect.a006080</pub-id><pub-id pub-id-type="pmid">26626938</pub-id>
</mixed-citation></ref><ref id="cit0017"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Green</surname>
<given-names>DR</given-names></string-name></person-group>. <article-title>The mitochondrial pathway of apoptosis part II: the Bcl-2 protein family</article-title>. <source>Cold Spring Harb Perspect Biol</source>. <year>2022</year>;<volume>14</volume>(<issue>6</issue>):<fpage>a041046</fpage>. doi: <pub-id pub-id-type="doi">10.1101/cshperspect.a041046</pub-id><pub-id pub-id-type="pmid">35701220</pub-id>
</mixed-citation></ref><ref id="cit0018"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dashzeveg</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Yoshida</surname>
<given-names>K</given-names></string-name></person-group>. <article-title>Cell death decision by p53 <italic toggle="yes">via</italic> control of the mitochondrial membrane</article-title>. <source>Cancer Lett</source>. <year>2015</year>;<volume>367</volume>(<issue>2</issue>):<fpage>108</fpage>&#x02013;<lpage>112</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.canlet.2015.07.019</pub-id><pub-id pub-id-type="pmid">26231733</pub-id>
</mixed-citation></ref><ref id="cit0019"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bortner</surname>
<given-names>CD</given-names></string-name>, <string-name><surname>Cidlowski</surname>
<given-names>JA</given-names></string-name></person-group>. <article-title>Cell shrinkage and monovalent cation fluxes: role in apoptosis</article-title>. <source>Arch Biochem Biophys</source>. <year>2007</year>;<volume>462</volume>(<issue>2</issue>):<fpage>176</fpage>&#x02013;<lpage>188</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.abb.2007.01.020</pub-id><pub-id pub-id-type="pmid">17321483</pub-id>
</mixed-citation></ref><ref id="cit0020"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lang</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Hoffmann</surname>
<given-names>EK</given-names></string-name></person-group>. <article-title>Role of ion transport in control of apoptotic cell death</article-title>. <source>Compr Physiol</source>. <year>2012</year>;<volume>2</volume>:<fpage>2037</fpage>&#x02013;<lpage>2061</lpage>. doi: <pub-id pub-id-type="doi">10.1002/cphy.c110046</pub-id><pub-id pub-id-type="pmid">23723032</pub-id>
</mixed-citation></ref><ref id="cit0021"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Poulsen</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Andersen</surname>
<given-names>EC</given-names></string-name>, <string-name><surname>Hansen</surname>
<given-names>CF</given-names></string-name>, et al</person-group>. <article-title>Deregulation of apoptotic volume decrease and ionic movements in multidrug-resistant tumor cells: role of chloride channels</article-title>. <source>Am J Physiol Cell Physiol</source>. <year>2010</year>;<volume>298</volume>(<issue>1</issue>):<fpage>C14</fpage>&#x02013;<lpage>25</lpage>. doi: <pub-id pub-id-type="doi">10.1152/ajpcell.00654.2008</pub-id><pub-id pub-id-type="pmid">19846756</pub-id>
</mixed-citation></ref><ref id="cit0022"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pedersen</surname>
<given-names>SF</given-names></string-name>, <string-name><surname>Klausen</surname>
<given-names>TK</given-names></string-name>, <string-name><surname>Nilius</surname>
<given-names>B</given-names></string-name></person-group>. <article-title>The identification of a volume-regulated anion channel: an amazing Odyssey</article-title>. <source>Acta Physiol (Oxf)</source>. <year>2015</year>;<volume>213</volume>(<issue>4</issue>):<fpage>868</fpage>&#x02013;<lpage>881</lpage>. doi: <pub-id pub-id-type="doi">10.1111/apha.12450</pub-id><pub-id pub-id-type="pmid">25565132</pub-id>
</mixed-citation></ref><ref id="cit0023"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jentsch</surname>
<given-names>TJ</given-names></string-name>, <string-name><surname>Lutter</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Planells-Cases</surname>
<given-names>R</given-names></string-name>, et al</person-group>. <article-title>VRAC: molecular identification as LRRC8 heteromers with differential functions</article-title>. <source>Pflugers Arch</source>. <year>2016</year>;<volume>468</volume>(<issue>3</issue>):<fpage>385</fpage>&#x02013;<lpage>393</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00424-015-1766-5</pub-id><pub-id pub-id-type="pmid">26635246</pub-id>
</mixed-citation></ref><ref id="cit0024"><label>[24]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Qiu</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Dubin</surname>
<given-names>AE</given-names></string-name>, <string-name><surname>Mathur</surname>
<given-names>J</given-names></string-name>, et al</person-group>. <article-title>SWELL1, a plasma membrane protein, is an essential component of volume-regulated anion channel</article-title>. <source>Cell</source>. <year>2014</year>;<volume>157</volume>(<issue>2</issue>):<fpage>447</fpage>&#x02013;<lpage>458</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2014.03.024</pub-id><pub-id pub-id-type="pmid">24725410</pub-id>
</mixed-citation></ref><ref id="cit0025"><label>[25]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Voss</surname>
<given-names>FK</given-names></string-name>, <string-name><surname>Ullrich</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Munch</surname>
<given-names>J</given-names></string-name>, et al</person-group>. <article-title>Identification of LRRC8 heteromers as an essential component of the volume-regulated anion channel VRAC</article-title>. <source>Science</source>. <year>2014</year>;<volume>344</volume>(<issue>6184</issue>):<fpage>634</fpage>&#x02013;<lpage>638</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.1252826</pub-id><pub-id pub-id-type="pmid">24790029</pub-id>
</mixed-citation></ref><ref id="cit0026"><label>[26]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Stauber</surname>
<given-names>T</given-names></string-name></person-group>. <article-title>The volume-regulated anion channel LRRC8/VRAC is dispensable for cell proliferation and migration</article-title>. <source>Int J Mol Sci</source>. <year>2019</year>;<volume>20</volume>(<issue>11</issue>):<fpage>2663</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms20112663</pub-id><pub-id pub-id-type="pmid">31151189</pub-id>
</mixed-citation></ref><ref id="cit0027"><label>[27]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gradogna</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gavazzo</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Boccaccio</surname>
<given-names>A</given-names></string-name>, et al</person-group>. <article-title>Subunit-dependent oxidative stress sensitivity of LRRC8 volume-regulated anion channels</article-title>. <source>J Physiol</source>. <year>2017</year>;<volume>595</volume>(<issue>21</issue>):<fpage>6719</fpage>&#x02013;<lpage>6733</lpage>. doi: <pub-id pub-id-type="doi">10.1113/JP274795</pub-id><pub-id pub-id-type="pmid">28841766</pub-id>
</mixed-citation></ref><ref id="cit0028"><label>[28]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kang</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Xie</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Gunasekar</surname>
<given-names>SK</given-names></string-name>, et al</person-group>. <article-title>SWELL1 is a glucose sensor regulating &#x003b2;-cell excitability and systemic glycaemia</article-title>. <source>Nat Commun</source>. <year>2018</year>;<volume>9</volume>(<issue>1</issue>):<fpage>367</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-017-02664-0</pub-id><pub-id pub-id-type="pmid">29371604</pub-id>
</mixed-citation></ref><ref id="cit0029"><label>[29]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhou</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Planells-Cases</surname>
<given-names>R</given-names></string-name>, et al</person-group>. <article-title>Transfer of cGAMP into bystander cells <italic toggle="yes">via</italic> LRRC8 volume-regulated anion channels augments STING-mediated interferon responses and anti-viral immunity</article-title>. <source>Immunity</source>. <year>2020</year>;<volume>52</volume>(<issue>5</issue>):<fpage>767</fpage>&#x02013;<lpage>781.e6</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2020.03.016</pub-id><pub-id pub-id-type="pmid">32277911</pub-id>
</mixed-citation></ref><ref id="cit0030"><label>[30]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname>
<given-names>C</given-names></string-name>, <string-name><surname>He</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>G</given-names></string-name>, et al</person-group>. <article-title>LRRC8A potentiates temozolomide sensitivity in glioma cells <italic toggle="yes">via</italic> activating mitochondria-dependent apoptotic pathway</article-title>. <source>Hum Cell</source>. <year>2019</year>;<volume>32</volume>(<issue>1</issue>):<fpage>41</fpage>&#x02013;<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s13577-018-0221-2</pub-id><pub-id pub-id-type="pmid">30426452</pub-id>
</mixed-citation></ref><ref id="cit0031"><label>[31]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rubino</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bach</surname>
<given-names>MD</given-names></string-name>, <string-name><surname>Schober</surname>
<given-names>AL</given-names></string-name>, et al</person-group>. <article-title>Downregulation of leucine-rich repeat-containing 8A limits proliferation and increases sensitivity of glioblastoma to temozolomide and carmustine</article-title>. <source>Front Oncol</source>. <year>2018</year>;<volume>8</volume>:<fpage>142</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fonc.2018.00142</pub-id><pub-id pub-id-type="pmid">29868469</pub-id>
</mixed-citation></ref><ref id="cit0032"><label>[32]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>S&#x000f8;rensen</surname>
<given-names>BH</given-names></string-name>, <string-name><surname>Dam</surname>
<given-names>CS</given-names></string-name>, <string-name><surname>St&#x000fc;rup</surname>
<given-names>S</given-names></string-name>, et al</person-group>. <article-title>Dual role of LRRC8A-containing transporters on cisplatin resistance in human ovarian cancer cells</article-title>. <source>J Inorg Biochem</source>. <year>2016</year>;<volume>160</volume>:<fpage>287</fpage>&#x02013;<lpage>295</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jinorgbio.2016.04.004</pub-id><pub-id pub-id-type="pmid">27112899</pub-id>
</mixed-citation></ref><ref id="cit0033"><label>[33]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Konishi</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Shiozaki</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kosuga</surname>
<given-names>T</given-names></string-name>, et al</person-group>. <article-title>LRRC8A expression influences growth of esophageal squamous cell carcinoma</article-title>. <source>Am J Pathol</source>. <year>2019</year>;<volume>189</volume>(<issue>10</issue>):<fpage>1973</fpage>&#x02013;<lpage>1985</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ajpath.2019.06.006</pub-id><pub-id pub-id-type="pmid">31323188</pub-id>
</mixed-citation></ref><ref id="cit0034"><label>[34]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ferrari</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Scalvini</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Losio</surname>
<given-names>MN</given-names></string-name>, et al</person-group>. <article-title>Establishment and characterization of two new pig cell lines for use in virological diagnostic laboratories</article-title>. <source>Journal Of Virological Methods</source>. <year>2003</year>;<volume>107</volume>(<issue>2</issue>):<fpage>205</fpage>&#x02013;<lpage>212</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0166-0934(02)00236-7</pub-id><pub-id pub-id-type="pmid">12505635</pub-id>
</mixed-citation></ref><ref id="cit0035"><label>[35]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gopalkrishna</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Verma</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kumbhar</surname>
<given-names>NS</given-names></string-name>, et al</person-group>. <article-title>Detection of <italic toggle="yes">mycoplasma</italic> species in cell culture by PCR and RFLP based method: effect of BM-cyclin to cure infections</article-title>. <source>Indian Journal Of Medical Microbiology</source>. <year>2007</year>;<volume>25</volume>(<issue>4</issue>):<fpage>364</fpage>&#x02013;<lpage>368</lpage>. doi: <pub-id pub-id-type="doi">10.4103/0255-0857.37340</pub-id><pub-id pub-id-type="pmid">18087086</pub-id>
</mixed-citation></ref><ref id="cit0036"><label>[36]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schmittgen</surname>
<given-names>TD</given-names></string-name>, <string-name><surname>Zakrajsek</surname>
<given-names>BA</given-names></string-name>, <string-name><surname>Mills</surname>
<given-names>AG</given-names></string-name>, et al</person-group>. <article-title>Quantitative reverse transcription&#x02013;polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods</article-title>. <source>Anal Biochem</source>. <year>2000</year>;<volume>285</volume>(<issue>2</issue>):<fpage>194</fpage>&#x02013;<lpage>204</lpage>. doi: <pub-id pub-id-type="doi">10.1006/abio.2000.4753</pub-id><pub-id pub-id-type="pmid">11017702</pub-id>
</mixed-citation></ref><ref id="cit0037"><label>[37]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>S&#x000f8;rensen</surname>
<given-names>BH</given-names></string-name>, <string-name><surname>Nielsen</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Thorsteinsdottir</surname>
<given-names>UA</given-names></string-name>, et al</person-group>. <article-title>Downregulation of LRRC8A protects human ovarian and alveolar carcinoma cells against cisplatin-induced expression of p53, MDM2, p21Waf1/Cip1, and caspase-9/-3 activation</article-title>. <source>Am J Physiol Cell Physiol</source>. <year>2016</year>;<volume>310</volume>(<issue>11</issue>):<fpage>C857</fpage>&#x02013;<lpage>873</lpage>. doi: <pub-id pub-id-type="doi">10.1152/ajpcell.00256.2015</pub-id><pub-id pub-id-type="pmid">26984736</pub-id>
</mixed-citation></ref><ref id="cit0038"><label>[38]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Okada</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Okada</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Sato-Numata</surname>
<given-names>K</given-names></string-name>, et al</person-group>. <article-title>Cell volume-activated and volume-correlated anion channels in mammalian cells: their biophysical, molecular, and pharmacological properties</article-title>. <source>Pharmacol Rev</source>. <year>2019</year>;<volume>71</volume>(<issue>1</issue>):<fpage>49</fpage>&#x02013;<lpage>88</lpage>. doi: <pub-id pub-id-type="doi">10.1124/pr.118.015917</pub-id><pub-id pub-id-type="pmid">30573636</pub-id>
</mixed-citation></ref><ref id="cit0039"><label>[39]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fedor</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Vignard</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Nicolau-Travers</surname>
<given-names>ML</given-names></string-name>, et al</person-group>. <article-title>From single-strand breaks to double-strand breaks during S-phase: a new mode of action of the <italic toggle="yes">Escherichia coli</italic> cytolethal distending toxin</article-title>. <source>Cell Microbiol</source>. <year>2013</year>;<volume>15</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.1111/cmi.12028</pub-id><pub-id pub-id-type="pmid">22978660</pub-id>
</mixed-citation></ref><ref id="cit0040"><label>[40]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jinadasa</surname>
<given-names>RN</given-names></string-name>, <string-name><surname>Bloom</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>Weiss</surname>
<given-names>RS</given-names></string-name>, et al</person-group>. <article-title>Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages</article-title>. <source>Microbiology (Reading)</source>. <year>2011</year>;<volume>157</volume>(<issue>7</issue>):<fpage>1851</fpage>&#x02013;<lpage>1875</lpage>. doi: <pub-id pub-id-type="doi">10.1099/mic.0.049536-0</pub-id><pub-id pub-id-type="pmid">21565933</pub-id>
</mixed-citation></ref><ref id="cit0041"><label>[41]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Macedo</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Rovira</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Torremorell</surname>
<given-names>M</given-names></string-name></person-group>. <article-title><italic toggle="yes">Haemophilus parasuis</italic>: infection, immunity and enrofloxacin</article-title>. <source>Vet Res</source>. <year>2015</year>;<volume>46</volume>(<issue>1</issue>):<fpage>128</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13567-015-0263-3</pub-id><pub-id pub-id-type="pmid">26511717</pub-id>
</mixed-citation></ref><ref id="cit0042"><label>[42]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Niu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, et al</person-group>. <article-title><italic toggle="yes">Haemophilus parasuis</italic> cytolethal distending toxin induces cell cycle arrest and p53-dependent apoptosis</article-title>. <source>PLoS One</source>. <year>2017</year>;<volume>12</volume>(<issue>5</issue>):<fpage>e0177199</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0177199</pub-id><pub-id pub-id-type="pmid">28545143</pub-id>
</mixed-citation></ref><ref id="cit0043"><label>[43]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shenker</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Walker</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Zekavat</surname>
<given-names>A</given-names></string-name>, et al</person-group>. <article-title>The cell-cycle regulatory protein p21(CIP1/WAF1) is required for cytolethal distending toxin (cdt)-induced apoptosis</article-title>. <source>Pathogens</source>. <year>2020</year>;<volume>9</volume>(<issue>1</issue>):<fpage>38</fpage>. doi: <pub-id pub-id-type="doi">10.3390/pathogens9010038</pub-id><pub-id pub-id-type="pmid">31906446</pub-id>
</mixed-citation></ref><ref id="cit0044"><label>[44]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wanitchakool</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Ousingsawat</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Sirianant</surname>
<given-names>L</given-names></string-name>, et al</person-group>. <article-title>Cl&#x02212; channels in apoptosis</article-title>. <source>Eur Biophys J</source>. <year>2016</year>;<volume>45</volume>(<issue>7</issue>):<fpage>599</fpage>&#x02013;<lpage>610</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00249-016-1140-3</pub-id><pub-id pub-id-type="pmid">27270446</pub-id>
</mixed-citation></ref><ref id="cit0045"><label>[45]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lu</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Ding</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>X</given-names></string-name>, et al</person-group>. <article-title>SWELL1 promotes cell growth and metastasis of hepatocellular carcinoma <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic></article-title>. <source>EBioMedicine</source>. <year>2019</year>;<volume>48</volume>:<fpage>100</fpage>&#x02013;<lpage>116</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ebiom.2019.09.007</pub-id><pub-id pub-id-type="pmid">31597595</pub-id>
</mixed-citation></ref><ref id="cit0046"><label>[46]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sabirov</surname>
<given-names>RZ</given-names></string-name>, <string-name><surname>Prenen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Tomita</surname>
<given-names>T</given-names></string-name>, et al</person-group>. <article-title>Reduction of ionic strength activates single volume-regulated anion channels (VRAC) in endothelial cells</article-title>. <source>Pflugers Arch</source>. <year>2000</year>;<volume>439</volume>(<issue>3</issue>):<fpage>315</fpage>&#x02013;<lpage>320</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s004249900186</pub-id><pub-id pub-id-type="pmid">10650983</pub-id>
</mixed-citation></ref><ref id="cit0047"><label>[47]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maeno</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Ishizaki</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Kanaseki</surname>
<given-names>T</given-names></string-name>, et al</person-group>. <article-title>Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2000</year>;<volume>97</volume>(<issue>17</issue>):<fpage>9487</fpage>&#x02013;<lpage>9492</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.140216197</pub-id><pub-id pub-id-type="pmid">10900263</pub-id>
</mixed-citation></ref></ref-list></back></article>
